Skip to main content

Developing and Sustaining an Effective and Resilient Oncology Careforce: A Workshop

Completed

Advances in cancer research, screening and diagnostic practices, and cancer treatment have led to improved outcomes for patients with cancer and a growing population of cancer survivors, but they have also increased the complexity of cancer care. Demographic trends, new payment models, growing emphasis on interprofessional practice, the widespread adoption of technologies in clinical practice, and a shift to the outpatient care delivery all have a profound effect on the cancer careforce. This workshop examined opportunities to better support the oncology careforce and improve the delivery of high-quality cancer care.

Description

An ad hoc committee will plan and host a 1.5-day public workshop that will examine the impact of evolving trends in cancer incidence and care on the oncology careforce and consider opportunities to enhance patient care through improved development and support of the careforce. The workshop will feature invited presentations and panel discussions on topics that may include:

  • Factors in the oncology care setting that contribute to inefficiencies, clinician burnout, and reduced quality of care (e.g., EHRs, documentation and other regulatory requirements, and pre-authorizations), as well as potential systems interventions to address these issues.
  • Approaches to stratify and optimize care across the cancer care continuum (e.g., for new vs. returning patients on active treatment vs. survivorship care).
  • The impact of new payment models, such as the CMS Oncology Care Model.
  • Approaches to improve the recruitment, training, mentorship, and retention of oncology care professionals.
  • Approaches to enhance cancer care competencies across the spectrum of non-oncology care providers, from physicians and advanced practice nurses to family caregivers.
  • Opportunities for collaboration and information-sharing among health care providers (e.g., physicians, nurses, home health care workers, and family caregivers) and across clinical specialties (e.g., oncology, primary care, cardiology, endocrinology) to identify best practices for careforce coordination and utilization.

The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.


Collaborators

Committee

Lisa K. Sheldon

Co-Chair

Lawrence N. Shulman

Co-Chair

Amy P. Abernethy

Member

Edward J. Benz, Jr.

Member

Robert W. Carlson

Member

Clese Erikson

Member

Stanton L. Gerson

Member

Lori Hoffman Hogg

Member

Ruth E. Nemire

Member

Randall A. Oyer

Member

David A. Siegel

Member

Virginia L. Valentin

Member

Robert A. Winn

Member

Sponsors

American Association for Cancer Research

American Cancer Society

American College of Radiology

American Society of Clinical Oncology

Association of American Cancer Institutes

Association of Community Cancer Centers

Bristol Myers Squibb

Cancer Support Community

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

Flatiron Health

Helsinn Therapeutics (U.S.), Inc.

LiveSTRONG Foundation

Merck

National Cancer Institute

National Comprehensive Cancer Network

National Institutes of Health

Novartis Oncology

Oncology Nursing Society

Pfizer Inc.

Staff

Erin Balogh

Lead

Sharyl Nass

Lead

Annalee Espinosa Gonzales

Micah Winograd

Emily Zevon

Ruth Cooper

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.